Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

CNBC

By Emma Newburger

June 26, 2021

Johnson & Johnson has agreed to a $230 million settlement with New York state that bars the company from promoting opioids and confirmed it has ended distribution of such products within the United States.

Read more…https://www.cnbc.com/2021/06/26/jj-agrees-to-stop-selling-opioids-in-230-million-settlement-with-new-york.html